Mu-opioid receptor – Alpha-2A adrenergic receptor heteromeric complex (MOR-alpha2AAR)

The Mu-opioid receptor – Alpha-2A adrenergic receptor (MOR-alpha2AAR) heteromeric complex is a functional protein assembly formed by the physical association of two distinct G protein-coupled receptors (Jordan et al., 2003; NIH). This heteromer is primarily located in the central nervous system, including the spinal cord and the nucleus tractus solitarius (NTS), where it plays a critical role in modulating pain perception and autonomic functions (Frontiers in Pharmacology, 2018). The physical interaction between MOR and alpha2AAR allows for complex allosteric cross-talk, where the activation of one receptor can significantly alter the signaling and trafficking of the other (Molecular Pharmacology, 2003). In the spinal cord, co-activation of these receptors is known to produce synergistic antinociception, making it a target for combined opioid-adrenergic therapies (NIH). Conversely, in the NTS, the heteromer is implicated in the regulation of blood pressure, where opioid-mediated inhibition of alpha2AAR activity can contribute to hypertensive states (Sun et al., 2015). Drugs such as morphine and clonidine interact with this complex, and their combined use is often explored to enhance analgesia while potentially mitigating the development of opioid tolerance (PubMed). Understanding the unique pharmacological profile of the MOR-alpha2AAR heteromer provides a foundation for developing more selective therapeutic agents for chronic pain and cardiovascular disorders (EBI ChEMBL).

Other names

MOR-alpha2AAR heteromerMOR-ADRA2A heteromerMu-opioid receptor/Alpha-2A adrenergic receptor complexMOR-alpha2AAR heterodimerMu-opioid receptor-alpha-2A adrenergic receptor complex

The mechanism involves direct physical association and allosteric modulation between the mu-opioid and alpha-2A adrenergic receptor protomers. Co-activation of both receptors can lead to negative cross-talk, reducing G-protein activation and ERK1/2 phosphorylation in certain tissues like the spinal cord, while in other contexts, the presence of one receptor potentiates the signaling of the other. In the nucleus tractus solitarius, the heteromer mediates opioid-induced inhibition of alpha-2A adrenergic signaling, contributing to blood pressure elevation.